Catalyst Wire Dossier Catalyst Wire Dossier

Envollizumab

null · null
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Envollizumab, covering 2023-08-25 to 2023-08-25. Get the full timeline:

Most recent: Clinical Trial Update: Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer [Phase 3]

See pricing